|
Name |
Accession |
Description |
Interval |
E-value |
| LCB5 |
COG1597 |
Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, ... |
1-296 |
1.86e-80 |
|
Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, General function prediction only];
Pssm-ID: 441205 [Multi-domain] Cd Length: 295 Bit Score: 245.53 E-value: 1.86e-80
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 1 MGKRMLFIFNPRAGKGSIKNRLVDILDIFVKAGYEVTVHPTQAYRDGQRVARR-KGGEYDLLVTSGGDGTLDEIVTGIMe 79
Cdd:COG1597 1 AMMRALLIVNPASGRGRAARLLERLVAALRAAGLEVEVLETESPGDATELAREaAAEGADLVVAAGGDGTVNEVANGLA- 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 80 gGHSTPVGYIPAGSTNDFANSLHVSKNMLEAAVDIVEGRAHAFDVGKFNDDFFVYIAAFGLFTDVSYETNQDLKNILGHA 159
Cdd:COG1597 80 -GTGPPLGILPLGTGNDFARALGIPLDPEAALEALLTGRTRRIDLGRVNGRYFLNVAGIGFDAEVVERANRALKRRLGKL 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 160 AYILEGTQRLFNIKSYNMTVESLECTMEGEFIFGMVSNATSVGGFRKLTgPDVMLDDGVFEVMLVhRPKNILELNEIIAS 239
Cdd:COG1597 159 AYVLAALRALLRYRPFRLRIELDGEEIEGEALLVAVGNGPYYGGGLRLA-PDASLDDGLLDVVVV-RPLSRLRLLRLLPR 236
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*....
gi 1575849863 240 MLGGA--DTKLIESFKTSSLRISCVGPVSWTLDGEFGGEHRDVEITNMKHAVQIMIAED 296
Cdd:COG1597 237 LLRGRhlRHPGVRYFRAREVEIESDRPLPVQLDGEPLGLATPLEFEVLPGALRVLVPAD 295
|
|
| PRK13337 |
PRK13337 |
putative lipid kinase; Reviewed |
3-297 |
1.36e-63 |
|
putative lipid kinase; Reviewed
Pssm-ID: 183982 [Multi-domain] Cd Length: 304 Bit Score: 202.97 E-value: 1.36e-63
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 3 KRMLFIFNPRAGKGSIKNRLVDILDIFVKAGYEVTVHPTQAYRDGQRVARRKG-GEYDLLVTSGGDGTLDEIVTGIMEGG 81
Cdd:PRK13337 2 KRARIIYNPTSGRELFKKNLPDVLQKLEQAGYETSAHATTGPGDATLAAERAVeRKFDLVIAAGGDGTLNEVVNGIAEKE 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 82 HSTPVGYIPAGSTNDFANSLHVSKNMLEAAVDIVEGRAHAFDVGKFNDDFFVYIAAFGLFTDVSYETNQDLKNILGHAAY 161
Cdd:PRK13337 82 NRPKLGIIPVGTTNDFARALHVPRDIEKAADVIIEGHTVPVDIGKANNRYFINIAGGGRLTELTYEVPSKLKTMLGQLAY 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 162 ILEGTQRLFNIKSYNMTVESLECTMEGEFIFGMVSNATSVGGFRKLTgPDVMLDDGVFEVMLVHRpKNILELNEIIASML 241
Cdd:PRK13337 162 YLKGIEMLPSLKATDVRIEYDGKLFQGEIMLFLLGLTNSVGGFEKLA-PDASLDDGYFDLIIVKK-ANLAELIHIATLAL 239
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*....
gi 1575849863 242 GGA---DTKLIESfKTSSLRISCVGPVSWTLDGEFGGEhRDVEITNMKHAVQIMIAEDD 297
Cdd:PRK13337 240 RGEhikHPKVIYT-KANRIKVSSFDKMQLNLDGEYGGK-LPAEFENLYRHIEVFVPKDQ 296
|
|
| TIGR00147 |
TIGR00147 |
lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been ... |
3-293 |
3.97e-47 |
|
lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been purified and shown to have phosphatidylglycerol kinase activity. The member from M. tuberculosis, Rv2252, has diacylglycerol kinase activity. BmrU from B. subtilis is in an operon with multidrug efflux transporter Bmr, but is uncharacterized. [Unknown function, Enzymes of unknown specificity]
Pssm-ID: 161732 [Multi-domain] Cd Length: 293 Bit Score: 159.98 E-value: 3.97e-47
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 3 KRMLFIFNPRAGKGSIKNRLVDILDIFVKAGYEVTVHPTQAYRDGQR-VARRKGGEYDLLVTSGGDGTLDEIVTGIMEGG 81
Cdd:TIGR00147 2 AEAPAILNPTAGKSNDNKPLREVIMLLREEGMEIHVRVTWEKGDAARyVEEARKFGVDTVIAGGGDGTINEVVNALIQLD 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 82 HSTPVGYIPAGSTNDFANSLHVSKNMLEAAVDIVEGRAHAFDVGKFNDDF-FVYIAAFGLFTDVSYETNQDLKNILGHAA 160
Cdd:TIGR00147 82 DIPALGILPLGTANDFARSLGIPEDLDKAAKLVIAGDARAIDMGQVNKQYcFINMAGGGFGTEITTETPEKLKAALGSLS 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 161 YILEGTQRLFNIKSYNMTVESLECTMEGEFIFGMVSNATSVGGFRKLTgPDVMLDDGVFEVMLVhRPKNILELNEIIASM 240
Cdd:TIGR00147 162 YILSGLMRMDTLQPFRCEIRGEGEHWQGEAVVFLVGNGRQAGGGQKLA-PDASINDGLLDLRIF-TNDNLLPALVLTLMS 239
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*
gi 1575849863 241 LGGADTKL--IESFKTSSLRISCVGPVSWTLDGEFGGeHRDVEITNMKHAVQIMI 293
Cdd:TIGR00147 240 DEGKHTDNpnIIYGKASRIDIQTPHKITFNLDGEPLG-GTPFHIEILPAHLRCRL 293
|
|
| DAGK_cat |
pfam00781 |
Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts ... |
4-126 |
4.85e-35 |
|
Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. The catalytic domain is assumed from the finding of bacterial homologs. YegS is the Escherichia coli protein in this family whose crystal structure reveals an active site in the inter-domain cleft formed by four conserved sequence motifs, revealing a novel metal-binding site. The residues of this site are conserved across the family.
Pssm-ID: 425868 [Multi-domain] Cd Length: 125 Bit Score: 123.08 E-value: 4.85e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 4 RMLFIFNPRAGKGSIKNRLVDILDIFVKAGYEVTVHPTQAYRDGQRVARR-KGGEYDLLVTSGGDGTLDEIVTGIMEGGH 82
Cdd:pfam00781 1 KLLVIVNPKSGGGKGKKLLRKVRPLLNKAGVEVELVLTEGPGDALELAREaAEDGYDRIVVAGGDGTVNEVLNGLAGLAT 80
|
90 100 110 120
....*....|....*....|....*....|....*....|....
gi 1575849863 83 STPVGYIPAGSTNDFANSLHVSKNMLEAAVDIVEGRAHAFDVGK 126
Cdd:pfam00781 81 RPPLGIIPLGTGNDFARALGIPGDPEEALEAILKGQTRPVDVGK 124
|
|
| DAGKc |
smart00046 |
Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger ... |
6-106 |
5.64e-08 |
|
Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. DAG can be produced from the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) by a phosphoinositide-specific phospholipase C and by the degradation of phosphatidylcholine (PC) by a phospholipase C or the concerted actions of phospholipase D and phosphatidate phosphohydrolase. This domain is presumed to be the catalytic domain. Bacterial homologues areknown.
Pssm-ID: 214487 [Multi-domain] Cd Length: 124 Bit Score: 50.37 E-value: 5.64e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 6 LFIFNPRAGKgsikNRLVDILDIFVKAG-----YEVTVH-PTQAYRDGQRVARrkggeYDLLVTSGGDGTLDEIVTGIME 79
Cdd:smart00046 1 LVFVNPKSGG----GKGEKLLRKFRLLLnprqvFDLTKKgPAVALVIFRDVPD-----FNRVLVCGGDGTVGWVLNALDK 71
|
90 100 110
....*....|....*....|....*....|
gi 1575849863 80 G---GHSTPVGYIPAGSTNDFANSLHVSKN 106
Cdd:smart00046 72 RelpLPEPPVAVLPLGTGNDLARSLGWGGG 101
|
|
|
|
Name |
Accession |
Description |
Interval |
E-value |
| LCB5 |
COG1597 |
Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, ... |
1-296 |
1.86e-80 |
|
Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, General function prediction only];
Pssm-ID: 441205 [Multi-domain] Cd Length: 295 Bit Score: 245.53 E-value: 1.86e-80
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 1 MGKRMLFIFNPRAGKGSIKNRLVDILDIFVKAGYEVTVHPTQAYRDGQRVARR-KGGEYDLLVTSGGDGTLDEIVTGIMe 79
Cdd:COG1597 1 AMMRALLIVNPASGRGRAARLLERLVAALRAAGLEVEVLETESPGDATELAREaAAEGADLVVAAGGDGTVNEVANGLA- 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 80 gGHSTPVGYIPAGSTNDFANSLHVSKNMLEAAVDIVEGRAHAFDVGKFNDDFFVYIAAFGLFTDVSYETNQDLKNILGHA 159
Cdd:COG1597 80 -GTGPPLGILPLGTGNDFARALGIPLDPEAALEALLTGRTRRIDLGRVNGRYFLNVAGIGFDAEVVERANRALKRRLGKL 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 160 AYILEGTQRLFNIKSYNMTVESLECTMEGEFIFGMVSNATSVGGFRKLTgPDVMLDDGVFEVMLVhRPKNILELNEIIAS 239
Cdd:COG1597 159 AYVLAALRALLRYRPFRLRIELDGEEIEGEALLVAVGNGPYYGGGLRLA-PDASLDDGLLDVVVV-RPLSRLRLLRLLPR 236
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*....
gi 1575849863 240 MLGGA--DTKLIESFKTSSLRISCVGPVSWTLDGEFGGEHRDVEITNMKHAVQIMIAED 296
Cdd:COG1597 237 LLRGRhlRHPGVRYFRAREVEIESDRPLPVQLDGEPLGLATPLEFEVLPGALRVLVPAD 295
|
|
| PRK13337 |
PRK13337 |
putative lipid kinase; Reviewed |
3-297 |
1.36e-63 |
|
putative lipid kinase; Reviewed
Pssm-ID: 183982 [Multi-domain] Cd Length: 304 Bit Score: 202.97 E-value: 1.36e-63
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 3 KRMLFIFNPRAGKGSIKNRLVDILDIFVKAGYEVTVHPTQAYRDGQRVARRKG-GEYDLLVTSGGDGTLDEIVTGIMEGG 81
Cdd:PRK13337 2 KRARIIYNPTSGRELFKKNLPDVLQKLEQAGYETSAHATTGPGDATLAAERAVeRKFDLVIAAGGDGTLNEVVNGIAEKE 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 82 HSTPVGYIPAGSTNDFANSLHVSKNMLEAAVDIVEGRAHAFDVGKFNDDFFVYIAAFGLFTDVSYETNQDLKNILGHAAY 161
Cdd:PRK13337 82 NRPKLGIIPVGTTNDFARALHVPRDIEKAADVIIEGHTVPVDIGKANNRYFINIAGGGRLTELTYEVPSKLKTMLGQLAY 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 162 ILEGTQRLFNIKSYNMTVESLECTMEGEFIFGMVSNATSVGGFRKLTgPDVMLDDGVFEVMLVHRpKNILELNEIIASML 241
Cdd:PRK13337 162 YLKGIEMLPSLKATDVRIEYDGKLFQGEIMLFLLGLTNSVGGFEKLA-PDASLDDGYFDLIIVKK-ANLAELIHIATLAL 239
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*....
gi 1575849863 242 GGA---DTKLIESfKTSSLRISCVGPVSWTLDGEFGGEhRDVEITNMKHAVQIMIAEDD 297
Cdd:PRK13337 240 RGEhikHPKVIYT-KANRIKVSSFDKMQLNLDGEYGGK-LPAEFENLYRHIEVFVPKDQ 296
|
|
| PRK13055 |
PRK13055 |
putative lipid kinase; Reviewed |
1-300 |
4.56e-61 |
|
putative lipid kinase; Reviewed
Pssm-ID: 237282 [Multi-domain] Cd Length: 334 Bit Score: 197.14 E-value: 4.56e-61
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 1 MGKRMLFIFNPRAGKGSIKNRLVDILDIFVKAGYEVTVHPTQAYRD-GQRVARR--KGGeYDLLVTSGGDGTLDEIVTGI 77
Cdd:PRK13055 1 MQKRARLIYNPTSGQEIMKKNVADILDILEQAGYETSAFQTTPEPNsAKNEAKRaaEAG-FDLIIAAGGDGTINEVVNGI 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 78 MEGGHSTPVGYIPAGSTNDFANSLHVSK-NMLEAAVDIVEGRAHAFDVGKFNDD-FFVYIAAFGLFTDVSYETNQDLKNI 155
Cdd:PRK13055 80 APLEKRPKMAIIPAGTTNDYARALKIPRdNPVEAAKVILKNQTIKMDIGRANEDkYFINIAAGGSLTELTYSVPSQLKSM 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 156 LGHAAYILEGTQRLFNIKSYNMTVESLECTMEGE--FIFGMVSNatSVGGFRKLTgPDVMLDDGVFEVMLVhRPKNILEL 233
Cdd:PRK13055 160 FGYLAYLAKGAELLPRVSPVPVRITYDEGVFEGKisMFFLALTN--SVGGFEQIV-PDAKLDDGKFTLIIV-KTANLFEL 235
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1575849863 234 NEIIASMLGGA---DTKLIESFKTSSLRISCVG--PVSWTLDGEFGGeHRDVEITNMKHAVQiMIAEDDTVP 300
Cdd:PRK13055 236 LHLMALILNGGkhiDDPRVIYIKTSKLTIEPLGddRLMVNLDGEYGG-DAPMTFENLKQHIE-FFANTDEIS 305
|
|
| PRK13059 |
PRK13059 |
putative lipid kinase; Reviewed |
3-292 |
1.01e-53 |
|
putative lipid kinase; Reviewed
Pssm-ID: 183858 Cd Length: 295 Bit Score: 177.15 E-value: 1.01e-53
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 3 KRMLFIFNPRAGKGSIKNRLVDILDIFVKAGYEVTVHPTQAYRDGQRVARRKGGEYDLLVTSGGDGTLDEIVTGIMEGGH 82
Cdd:PRK13059 2 KKVKFIYNPYSGENAIISELDKVIRIHQEKGYLVVPYRISLEYDLKNAFKDIDESYKYILIAGGDGTVDNVVNAMKKLNI 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 83 STPVGYIPAGSTNDFANSLHVSKNMLEAAVDIVEGRAHAFDVGKFNDDFFVYIAAFGLFTDVSYETNQDLKNILGHAAYI 162
Cdd:PRK13059 82 DLPIGILPVGTANDFAKFLGMPTDIGEACEQILKSKPKKVDLGKINDKYFINVASTGLFTDVSQKTDVNLKNTIGKLAYY 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 163 LEGTQRLFNIKSYNMTVESLECTMEGEFIFGMVSNATSVGGFRKLTGPDVmlDDGVFEVMLVhRPKNILELNEIIASMLG 242
Cdd:PRK13059 162 LKGLEELPNFRKLKVKVTSEEVNFDGDMYLMLVFNGQTAGNFNLAYKAEV--DDGLLDVIII-KACPIIDLIPLFIKVLK 238
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|...
gi 1575849863 243 GA---DTKLIESFKTSSLRISCVGPVSWTLDGEfGGEHRDVEITNMKHAVQIM 292
Cdd:PRK13059 239 GEhleDVNGLIYFKTDKLEIESNEEIVTDIDGE-RGPDFPLNIECIKGGLKVL 290
|
|
| TIGR00147 |
TIGR00147 |
lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been ... |
3-293 |
3.97e-47 |
|
lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been purified and shown to have phosphatidylglycerol kinase activity. The member from M. tuberculosis, Rv2252, has diacylglycerol kinase activity. BmrU from B. subtilis is in an operon with multidrug efflux transporter Bmr, but is uncharacterized. [Unknown function, Enzymes of unknown specificity]
Pssm-ID: 161732 [Multi-domain] Cd Length: 293 Bit Score: 159.98 E-value: 3.97e-47
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 3 KRMLFIFNPRAGKGSIKNRLVDILDIFVKAGYEVTVHPTQAYRDGQR-VARRKGGEYDLLVTSGGDGTLDEIVTGIMEGG 81
Cdd:TIGR00147 2 AEAPAILNPTAGKSNDNKPLREVIMLLREEGMEIHVRVTWEKGDAARyVEEARKFGVDTVIAGGGDGTINEVVNALIQLD 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 82 HSTPVGYIPAGSTNDFANSLHVSKNMLEAAVDIVEGRAHAFDVGKFNDDF-FVYIAAFGLFTDVSYETNQDLKNILGHAA 160
Cdd:TIGR00147 82 DIPALGILPLGTANDFARSLGIPEDLDKAAKLVIAGDARAIDMGQVNKQYcFINMAGGGFGTEITTETPEKLKAALGSLS 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 161 YILEGTQRLFNIKSYNMTVESLECTMEGEFIFGMVSNATSVGGFRKLTgPDVMLDDGVFEVMLVhRPKNILELNEIIASM 240
Cdd:TIGR00147 162 YILSGLMRMDTLQPFRCEIRGEGEHWQGEAVVFLVGNGRQAGGGQKLA-PDASINDGLLDLRIF-TNDNLLPALVLTLMS 239
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*
gi 1575849863 241 LGGADTKL--IESFKTSSLRISCVGPVSWTLDGEFGGeHRDVEITNMKHAVQIMI 293
Cdd:TIGR00147 240 DEGKHTDNpnIIYGKASRIDIQTPHKITFNLDGEPLG-GTPFHIEILPAHLRCRL 293
|
|
| DAGK_cat |
pfam00781 |
Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts ... |
4-126 |
4.85e-35 |
|
Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. The catalytic domain is assumed from the finding of bacterial homologs. YegS is the Escherichia coli protein in this family whose crystal structure reveals an active site in the inter-domain cleft formed by four conserved sequence motifs, revealing a novel metal-binding site. The residues of this site are conserved across the family.
Pssm-ID: 425868 [Multi-domain] Cd Length: 125 Bit Score: 123.08 E-value: 4.85e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 4 RMLFIFNPRAGKGSIKNRLVDILDIFVKAGYEVTVHPTQAYRDGQRVARR-KGGEYDLLVTSGGDGTLDEIVTGIMEGGH 82
Cdd:pfam00781 1 KLLVIVNPKSGGGKGKKLLRKVRPLLNKAGVEVELVLTEGPGDALELAREaAEDGYDRIVVAGGDGTVNEVLNGLAGLAT 80
|
90 100 110 120
....*....|....*....|....*....|....*....|....
gi 1575849863 83 STPVGYIPAGSTNDFANSLHVSKNMLEAAVDIVEGRAHAFDVGK 126
Cdd:pfam00781 81 RPPLGIIPLGTGNDFARALGIPGDPEEALEAILKGQTRPVDVGK 124
|
|
| PRK13054 |
PRK13054 |
lipid kinase; Reviewed |
31-272 |
1.19e-34 |
|
lipid kinase; Reviewed
Pssm-ID: 237281 [Multi-domain] Cd Length: 300 Bit Score: 127.30 E-value: 1.19e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 31 KAGYEVTVHPTQAYRDGQRVAR--RKGGeYDLLVTSGGDGTLDEIVTGIM--EGGHSTPVGYIPAGSTNDFANSLHVSKN 106
Cdd:PRK13054 29 EEGHTLHVRVTWEKGDAARYVEeaLALG-VATVIAGGGDGTINEVATALAqlEGDARPALGILPLGTANDFATAAGIPLE 107
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 107 MLEAAVDIVEGRAHAFDVGKFNDD-FFVYIAAFGLFTDVSYETNQDLKNILGHAAYILEGTQRLFNIKSYNMTVESLECT 185
Cdd:PRK13054 108 PDKALKLAIEGRAQPIDLARVNDRtYFINMATGGFGTRVTTETPEKLKAALGGVAYLIHGLMRMDTLKPDRCEIRGPDFH 187
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 186 MEGEFIFGMVSNATSVGGFRKLTgPDVMLDDGVFEVMLVHRPKNIL-ELNEIIASmlGGADTKLIESFKTSSLRISCVGP 264
Cdd:PRK13054 188 WQGDALVIGIGNGRQAGGGQQLC-PEALINDGLLDLRILPAPQELLpTLLSTLTG--GSEDNPNIIRARLPWLEIQAPHE 264
|
....*...
gi 1575849863 265 VSWTLDGE 272
Cdd:PRK13054 265 LTFNLDGE 272
|
|
| PRK00861 |
PRK00861 |
putative lipid kinase; Reviewed |
1-298 |
4.41e-27 |
|
putative lipid kinase; Reviewed
Pssm-ID: 234850 [Multi-domain] Cd Length: 300 Bit Score: 107.40 E-value: 4.41e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 1 MGKRMLFIFNPRAGKG-------SIKNRLVDILDIFVkagYEVT--VHPTQAYRDgqrvARRKGgeYDLLVTSGGDGTLD 71
Cdd:PRK00861 1 MTRSACLIFNPVAGQGnpevdlaLIRAILEPEMDLDI---YLTTpeIGADQLAQE----AIERG--AELIIASGGDGTLS 71
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 72 EIVTGIMEGGhsTPVGYIPAGSTNDFANSLHVSKNMLEAAVDIVEGRAHAFDVGKFNDDFFVYIAAFGLFTDVSYETNQD 151
Cdd:PRK00861 72 AVAGALIGTD--IPLGIIPRGTANAFAAALGIPDTIEEACRTILQGKTRRVDVAYCNGQPMILLAGIGFEAETVEEADRE 149
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 152 LKNILGHAAYILEGTQRLFNIKSYNMTVESLECTMEGEFIFGMVSNA---TSV--GGFrkltgPDVMLDDGVFEVMLVhR 226
Cdd:PRK00861 150 AKNRFGILAYILSGLQQLRELESFEVEIETEDQIITTNAVAVTVANAappTSVlaQGP-----GAVIPDDGLLDVTIV-A 223
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1575849863 227 PKNILEL----NEIIASMLGG--ADTKLIESFKTSSLRISCVGPVSWTLDGEFGGEhRDVEITNMKHAVQIMIAEDDT 298
Cdd:PRK00861 224 PKNLAEAvaasYHLLQTALQGnpAERDDIGYLRAKQVKITTDPPQKVVIDGEVVGT-TPIEIECLPRSLKVFAPLQAE 300
|
|
| PRK13057 |
PRK13057 |
lipid kinase; |
6-161 |
4.12e-18 |
|
lipid kinase;
Pssm-ID: 183857 [Multi-domain] Cd Length: 287 Bit Score: 82.27 E-value: 4.12e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 6 LFIFNPRAGKGsiKNRLVDILDIFVKAGYEVTVHPTQAYRDGQRVARRKGGEYDLLVTSGGDGTLDEIVTGIMEGGhsTP 85
Cdd:PRK13057 1 LLLVNRHARSG--RAALAAARAALEAAGLELVEPPAEDPDDLSEVIEAYADGVDLVIVGGGDGTLNAAAPALVETG--LP 76
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1575849863 86 VGYIPAGSTNDFANSLHVSKNMLEAAVDIVEGRAHAFDVGKFNDDFFVYIAAFGLFTDVSYETNQDLKNILGHAAY 161
Cdd:PRK13057 77 LGILPLGTANDLARTLGIPLDLEAAARVIATGQVRRIDLGWVNGHYFFNVASLGLSAELARRLTKELKRRWGTLGY 152
|
|
| PLN02958 |
PLN02958 |
diacylglycerol kinase/D-erythro-sphingosine kinase |
3-176 |
1.51e-11 |
|
diacylglycerol kinase/D-erythro-sphingosine kinase
Pssm-ID: 215517 [Multi-domain] Cd Length: 481 Bit Score: 64.50 E-value: 1.51e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 3 KRMLFIFNPRAGKGSIKNRLVDILD-IFVKAGYEVTVHPTQAYRDGQRVARRKG-GEYDLLVTSGGDGTLDEIVTGIME- 79
Cdd:PLN02958 112 KRLLVFVNPFGGKKSASKIFFDVVKpLLEDADIQLTIQETKYQLHAKEVVRTMDlSKYDGIVCVSGDGILVEVVNGLLEr 191
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 80 ----GGHSTPVGYIPAGSTNDFANSLHVSKNM----LEAAVDIVEGRAHAFDVG-------KFnddFFVYIAAFGLFTDV 144
Cdd:PLN02958 192 edwkTAIKLPIGMVPAGTGNGMAKSLLDSVGEpcsaTNAVLAIIRGHKCSLDVAtilqgetKF---FSVLMLAWGLVADI 268
|
170 180 190
....*....|....*....|....*....|..
gi 1575849863 145 SYETNQdlKNILGHAAYILEGTQRLFNIKSYN 176
Cdd:PLN02958 269 DIESEK--YRWMGSARLDFYGLQRILCLRQYN 298
|
|
| PRK12361 |
PRK12361 |
hypothetical protein; Provisional |
3-282 |
1.63e-10 |
|
hypothetical protein; Provisional
Pssm-ID: 183473 [Multi-domain] Cd Length: 547 Bit Score: 61.56 E-value: 1.63e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 3 KRMLFIFNPRAGKGSIKNRLVDILDiFVKAGYEVTVHPTQAYRDGQRVAR--RKGGEyDLLVTSGGDGTLDEIVTGIMeg 80
Cdd:PRK12361 243 KRAWLIANPVSGGGKWQEYGEQIQR-ELKAYFDLTVKLTTPEISAEALAKqaRKAGA-DIVIACGGDGTVTEVASELV-- 318
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 81 GHSTPVGYIPAGSTNDFANSLHVSKNML---EAAVD-IVEGRAHAFDVGKFNDDFFVYIAAFGLFTDVSYETNQDLKNIL 156
Cdd:PRK12361 319 NTDITLGIIPLGTANALSHALFGLGSKLipvEQACDnIIQGHTQRIDTARCNDRLMLLLVGIGFEQKMIESADRERKNAL 398
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 157 GHAAYiLEGTQRLFNiksyNMTVESLECTMEGEFIFGM------VSNA---TSV----GGfrkltGPDVmlDDGVFEVML 223
Cdd:PRK12361 399 GQLAY-LDGLWRAVN----ENETLTLTVTLDDAEPQTIsthslvVANAapfTSLlaqgGG-----EPNM--TDGLLDITW 466
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1575849863 224 VHR----PKNILELNE-IIASMLGGADTKLIESFKTSSLRISCVGPVSWTLDGE-FGGEHRDVEI 282
Cdd:PRK12361 467 LDSggepGEQLLSLAElALSGLGKEPEANKVHHAHAKKVTISSQKPIKYVIDGElFEDEDLTIEV 531
|
|
| DAGKc |
smart00046 |
Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger ... |
6-106 |
5.64e-08 |
|
Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. DAG can be produced from the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) by a phosphoinositide-specific phospholipase C and by the degradation of phosphatidylcholine (PC) by a phospholipase C or the concerted actions of phospholipase D and phosphatidate phosphohydrolase. This domain is presumed to be the catalytic domain. Bacterial homologues areknown.
Pssm-ID: 214487 [Multi-domain] Cd Length: 124 Bit Score: 50.37 E-value: 5.64e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 6 LFIFNPRAGKgsikNRLVDILDIFVKAG-----YEVTVH-PTQAYRDGQRVARrkggeYDLLVTSGGDGTLDEIVTGIME 79
Cdd:smart00046 1 LVFVNPKSGG----GKGEKLLRKFRLLLnprqvFDLTKKgPAVALVIFRDVPD-----FNRVLVCGGDGTVGWVLNALDK 71
|
90 100 110
....*....|....*....|....*....|
gi 1575849863 80 G---GHSTPVGYIPAGSTNDFANSLHVSKN 106
Cdd:smart00046 72 RelpLPEPPVAVLPLGTGNDLARSLGWGGG 101
|
|
| PRK11914 |
PRK11914 |
diacylglycerol kinase; Reviewed |
59-292 |
4.10e-06 |
|
diacylglycerol kinase; Reviewed
Pssm-ID: 237021 [Multi-domain] Cd Length: 306 Bit Score: 47.47 E-value: 4.10e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 59 DLLVTSGGDGTldeIVTGIMEGGHS-TPVGYIPAGSTNDFANSLHVSKNMLEAAVD-IVEGRAHAFDVGKFNDD-----F 131
Cdd:PRK11914 66 DALVVVGGDGV---ISNALQVLAGTdIPLGIIPAGTGNDHAREFGIPTGDPEAAADvIVDGWTETVDLGRIQDDdgivkW 142
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 132 FVYIAAFGLFTDVSYETNQdLKNILGHAAYILEGTQRLFNIK--SYNMTVESLEcTMEGEFIFGMVSNATSVGGFRKLTg 209
Cdd:PRK11914 143 FGTVAATGFDSLVTDRANR-MRWPHGRMRYNLAMLAELSKLRplPFRLVLDGTE-EIVTDLTLAAFGNTRSYGGGMLIC- 219
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 210 PDVMLDDGVFEVMLVHRPKNiLELNEIIASMLGGADTKL--IESFKTSSLRISCVGPVSWTlDGEFGGEhRDVEITNMKH 287
Cdd:PRK11914 220 PNADHTDGLLDITMVQSASR-TRLLRLFPTVFKGTHVELdeVSTARAKTVHVECPGINAYA-DGDFACP-LPAEISAVPG 296
|
....*
gi 1575849863 288 AVQIM 292
Cdd:PRK11914 297 ALQIL 301
|
|
| PLN02204 |
PLN02204 |
diacylglycerol kinase |
3-108 |
1.96e-03 |
|
diacylglycerol kinase
Pssm-ID: 215126 [Multi-domain] Cd Length: 601 Bit Score: 39.87 E-value: 1.96e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1575849863 3 KRMLFIFNPRAGKGSIKNRLVDILDIFVKAGYEVTVHPTQ----AYRDGQRVARRKGGEYDLLVTSGGDGTLDEIVTGIM 78
Cdd:PLN02204 160 KNLLVFVHPLSGKGSGSRTWETVSPIFIRAKVKTKVIVTEraghAFDVMASISNKELKSYDGVIAVGGDGFFNEILNGYL 239
|
90 100 110
....*....|....*....|....*....|
gi 1575849863 79 EGGHSTPvgYIPAGStnDFANSLHVSKNML 108
Cdd:PLN02204 240 LSRLKVP--YPPSPS--DSVHSVQSRGSSS 265
|
|
|